Delivery Order SPE2DB22D3016-SPE2DB25FBAB3
Award Date
6/23/25
Potential Completion Date
6/24/25
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of VALSARTAN-HCTZ 160-12.5 MG TAB 90S. The $8,953.53 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of November 25, 2024. The contract is not designated with a set-aside requirement. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
The U.S. Defense Logistics Agency (DLA) awarded a $6,894.05 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,062,501 units of Valsartan-HCTZ 320-12.5 mg tablets. The contract has an ultimate completion date of January 29, 2025. This contract is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $6,495.77 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VALSARTAN-HCTZ 80-12.5 MG TAB 90S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
The federal contract award is for the delivery of Valsartan-HCTZ 80-12.5 mg tablets, with a ceiling value of $9,807.11 and a completion date of July 24, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that is registered in the System for Award Management (SAM.gov). The contract was awarded by the Defense Logistics Agency (DLA), a defense agency that supports the U.S. military's medical needs. The contract is a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $4,136.19 firm-fixed-price delivery order is for 4,568,236,565 units of the medication Valsartan-HCTZ 80-12.5 mg tablets. The contract has a period of performance through May 14, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of Valsartan-HCTZ 320-12.5 mg tablets in 90-count bottles to the Defense Logistics Agency (DLA). The $24,044.29 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The award has an ultimate completion date of January 12, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,101.61 Firm Fixed Price delivery order is for the supply of 4568160926 - VALSARTAN-HCTZ 320-25 MG TAB 90S, with a performance period through May 7, 2025. The contract is not set aside and was awarded on May 6, 2025. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Valsartan-HCTZ 160-12.5 mg tablets. The $5,218.36 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical on September 4, 2024, with a completion date of September 5, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award is for the delivery of Valsartan-HCTZ 320-12.5 mg tablets to the Defense Logistics Agency (DLA), a major defense agency under the Department of Defense. The $1,731.54 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a large pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of May 24, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award is for the delivery of Valsartan-HCTZ 80-12.5 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $20,952.43 and is a firm fixed price delivery order with a completion date of May 28, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set-aside and is an open competition. Amerisourcebergen Drug Corp holds a significant...